Published in CNS Neurol Disord Drug Targets on August 01, 2009
Control of sleep and wakefulness. Physiol Rev (2012) 3.06
Narcolepsy: neural mechanisms of sleepiness and cataplexy. J Neurosci (2012) 1.07
Animal models of sleep disorders. Comp Med (2013) 0.82
Sleep disorders, obesity, and aging: the role of orexin. Ageing Res Rev (2014) 0.81
Narcolepsy and A(H1N1)pdm09 vaccination: shaping the research on the observed signal. Hum Vaccin Immunother (2013) 0.81
Effects of orexin 2 receptor activation on apnea in the C57BL/6J mouse. Respir Physiol Neurobiol (2014) 0.80
Knockdown of orexin type 2 receptor in the lateral pontomesencephalic tegmentum of rats increases REM sleep. Eur J Neurosci (2013) 0.78
Shining evolutionary light on human sleep and sleep disorders. Evol Med Public Health (2016) 0.75
The anatomical, cellular and synaptic basis of motor atonia during rapid eye movement sleep. J Physiol (2016) 0.75
Parkinson Disease: An Evolutionary Perspective. Front Neurol (2017) 0.75
Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell (1998) 12.66
Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell (1999) 9.84
The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A (1998) 9.32
Neural substrates of awakening probed with optogenetic control of hypocretin neurons. Nature (2007) 8.22
The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell (1999) 7.99
Hypocretin (orexin) deficiency in human narcolepsy. Lancet (2000) 7.92
A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med (2000) 7.05
Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. Sleep (1986) 6.04
Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron (2001) 5.09
Narcolepsy with cataplexy. Lancet (2007) 4.81
Promotion of sleep by targeting the orexin system in rats, dogs and humans. Nat Med (2007) 3.25
Dopaminergic role in stimulant-induced wakefulness. J Neurosci (2001) 2.91
Hypocretin/orexin overexpression induces an insomnia-like phenotype in zebrafish. J Neurosci (2006) 2.86
To eat or to sleep? Orexin in the regulation of feeding and wakefulness. Annu Rev Neurosci (2001) 2.84
Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes. Neuron (2003) 2.73
Behavioral state instability in orexin knock-out mice. J Neurosci (2004) 2.56
Neurobiology of REM and NREM sleep. Sleep Med (2007) 2.52
The physiology of brain histamine. Prog Neurobiol (2001) 2.45
Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins/hypocretins. J Neurosci (2003) 2.43
Characterization of sleep in zebrafish and insomnia in hypocretin receptor mutants. PLoS Biol (2007) 2.34
Concomitant loss of dynorphin, NARP, and orexin in narcolepsy. Neurology (2005) 2.33
Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system. J Comp Neurol (1999) 2.32
The epidemiology of narcolepsy. Sleep (2007) 2.28
Arousal effect of orexin A depends on activation of the histaminergic system. Proc Natl Acad Sci U S A (2001) 2.20
Variant between CPT1B and CHKB associated with susceptibility to narcolepsy. Nat Genet (2008) 2.09
Criteria for the diagnosis of the narcoleptic syndrome. Proc Staff Meet Mayo Clin (1957) 1.89
Hypocretin-2-saporin lesions of the lateral hypothalamus produce narcoleptic-like sleep behavior in the rat. J Neurosci (2001) 1.86
Orexin/hypocretin excites the histaminergic neurons of the tuberomammillary nucleus. J Neurosci (2001) 1.81
Elevated body temperature during sleep in orexin knockout mice. Am J Physiol Regul Integr Comp Physiol (2006) 1.71
Difference in obesity phenotype between orexin-knockout mice and orexin neuron-deficient mice with same genetic background and environmental conditions. Neurosci Lett (2005) 1.64
Narp immunostaining of human hypocretin (orexin) neurons: loss in narcolepsy. Neurology (2005) 1.64
Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice. Proc Natl Acad Sci U S A (2004) 1.61
Identification and functional analysis of mutations in the hypocretin (orexin) genes of narcoleptic canines. Genome Res (2001) 1.59
Expression of a poly-glutamine-ataxin-3 transgene in orexin neurons induces narcolepsy-cataplexy in the rat. J Neurosci (2004) 1.55
A consensus definition of cataplexy in mouse models of narcolepsy. Sleep (2009) 1.55
Cataplexy-active neurons in the hypothalamus: implications for the role of histamine in sleep and waking behavior. Neuron (2004) 1.55
Pharmacological aspects of human and canine narcolepsy. Prog Neurobiol (1997) 1.53
Weak with laughter. Lancet (1999) 1.49
Familial occurrence of narcolepsy in miniature horses. Equine Vet J (1993) 1.40
Orexin A excites serotonergic neurons in the dorsal raphe nucleus of the rat. Neuropharmacology (2001) 1.40
Locus coeruleus neurons: cessation of activity during cataplexy. Neuroscience (1999) 1.38
Orexins activate histaminergic neurons via the orexin 2 receptor. Biochem Biophys Res Commun (2002) 1.33
Sleep/wake fragmentation disrupts metabolism in a mouse model of narcolepsy. J Physiol (2007) 1.30
Construction and characterization of an eightfold redundant dog genomic bacterial artificial chromosome library. Genomics (1999) 1.30
Narcolepsy: immunological aspects. Sleep Med Rev (2008) 1.28
Running promotes wakefulness and increases cataplexy in orexin knockout mice. Sleep (2007) 1.26
Clinical and neurobiological aspects of narcolepsy. Sleep Med (2007) 1.26
Neuronal activity in narcolepsy: identification of cataplexy-related cells in the medial medulla. Science (1991) 1.25
CSF hypocretin-1 assessment in sleep and neurological disorders. Lancet Neurol (2008) 1.24
Hypocretin release in normal and narcoleptic dogs after food and sleep deprivation, eating, and movement. Am J Physiol Regul Integr Comp Physiol (2002) 1.23
Cataplexy-related neurons in the amygdala of the narcoleptic dog. Neuroscience (2002) 1.21
Effects of lateral hypothalamic lesion with the neurotoxin hypocretin-2-saporin on sleep in Long-Evans rats. Neuroscience (2003) 1.21
Activity of dorsal raphe cells across the sleep-waking cycle and during cataplexy in narcoleptic dogs. J Physiol (2004) 1.19
Developmental divergence of sleep-wake patterns in orexin knockout and wild-type mice. Eur J Neurosci (2007) 1.17
Decreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controls. Sleep (2009) 1.16
Evidence implicating a role for orexin-1 receptor modulation of paradoxical sleep in the rat. Neurosci Lett (2003) 1.16
Delayed orexin signaling consolidates wakefulness and sleep: physiology and modeling. J Neurophysiol (2008) 1.16
An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin-/- mice and patients. Neurobiol Dis (2007) 1.15
Modafinil more effectively induces wakefulness in orexin-null mice than in wild-type littermates. Neuroscience (2005) 1.14
Increased dopaminergic transmission mediates the wake-promoting effects of CNS stimulants. Sleep Res Online (1998) 1.14
CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome. Sleep (2009) 1.13
Nocturnal aspects of narcolepsy with cataplexy. Sleep Med Rev (2008) 1.11
REM sleep changes in rats induced by siRNA-mediated orexin knockdown. Eur J Neurosci (2006) 1.11
Neuroevolutionary sources of laughter and social joy: modeling primal human laughter in laboratory rats. Behav Brain Res (2007) 1.10
The development of hypocretin (orexin) deficiency in hypocretin/ataxin-3 transgenic rats. Neuroscience (2007) 1.09
Murine Multiple Sleep Latency Test: phenotyping sleep propensity in mice. Sleep (2004) 1.06
Decreased brain histamine content in hypocretin/orexin receptor-2 mutated narcoleptic dogs. Neurosci Lett (2001) 1.04
Effects of thyrotropin-releasing hormone and its analogs on daytime sleepiness and cataplexy in canine narcolepsy. J Neurosci (1997) 1.03
Hypocretin levels in sporadic and familial cases of canine narcolepsy. Neurobiol Dis (2001) 1.02
Histamine H3 receptor antagonists: from target identification to drug leads. Biochem Pharmacol (2006) 1.01
Orexin (hypocretin) gene transfer diminishes narcoleptic sleep behavior in mice. Eur J Neurosci (2008) 1.01
Systemic administration of hypocretin-1 reduces cataplexy and normalizes sleep and waking durations in narcoleptic dogs. Sleep Res Online (2000) 1.00
REM sleep enhancement and behavioral cataplexy following orexin (hypocretin)-II receptor antisense perfusion in the pontine reticular formation. Sleep Res Online (1999) 1.00
Is narcolepsy a REM sleep disorder? Analysis of sleep abnormalities in narcoleptic Dobermans. Neurosci Res (2000) 0.99
A video-polygraphic analysis of the cataplectic attack. Clin Neurophysiol (2000) 0.99
Treatment with immunosuppressive and anti-inflammatory agents delays onset of canine genetic narcolepsy and reduces symptom severity. Exp Neurol (2004) 0.99
Cytokines and pathological sleep. Sleep Med (2007) 0.98
Narcolepsy: current treatment options and future approaches. Neuropsychiatr Dis Treat (2008) 0.96
Electroencephalographic correlates of cataplectic attacks in narcoleptic canines. Electroencephalogr Clin Neurophysiol (1985) 0.96
Chronic oral administration of CG-3703, a thyrotropin releasing hormone analog, increases wake and decreases cataplexy in canine narcolepsy. Neuropsychopharmacology (2000) 0.95
Neuronal degeneration in canine narcolepsy. J Neurosci (1999) 0.95
Sleep in the Wistar-Kyoto rat, a putative genetic animal model for depression. Neuroreport (2000) 0.95
Implication of dopaminergic mechanisms in the wake-promoting effects of amphetamine: a study of D- and L-derivatives in canine narcolepsy. Neuroscience (2000) 0.92
Orexins: from neuropeptides to energy homeostasis and sleep/wake regulation. J Mol Med (Berl) (2002) 0.92
Selective excitation of GABAergic neurons in the substantia nigra of the rat by orexin/hypocretin in vitro. Regul Pept (2002) 0.92
Narcolepsy and the HLA region. J Neuroimmunol (2001) 0.92
Muscle atonia is triggered by cholinergic stimulation of the basal forebrain: implication for the pathophysiology of canine narcolepsy. J Neurosci (1995) 0.91
Muscarinic cholinergic receptors and the canine model of narcolepsy. Sleep (1986) 0.90
Hypocretin receptor expression in canine and murine narcolepsy models and in hypocretin-ligand deficient human narcolepsy. Sleep (2008) 0.90
The amygdala: a critical modulator of sensory influence on sleep. Biol Signals Recept (2000) 0.89
Comparative effects of modafinil and amphetamine on daytime sleepiness and cataplexy of narcoleptic dogs. Sleep (1995) 0.89
Activity of pontine neurons during sleep and cataplexy in hypocretin knock-out mice. J Neurosci (2009) 0.89
Canine model of narcolepsy: genetic and developmental determinants. Exp Neurol (1982) 0.89
Sex difference in body weight gain and leptin signaling in hypocretin/orexin deficient mouse models. Peptides (2006) 0.89
Feeding-elicited cataplexy in orexin knockout mice. Neuroscience (2009) 0.89
Genetic linkage of autosomal recessive canine narcolepsy with a mu immunoglobulin heavy-chain switch-like segment. Proc Natl Acad Sci U S A (1991) 0.89
Genetic factors in canine narcolepsy. Sleep (1979) 0.88
Cholinergic mechanisms in canine narcolepsy--I. Modulation of cataplexy via local drug administration into the pontine reticular formation. Neuroscience (1994) 0.88
M2 muscarinic receptors in pontine reticular formation of C57BL/6J mouse contribute to rapid eye movement sleep generation. Neuroscience (2004) 0.88
Sulpiride, a D2/D3 blocker, reduces cataplexy but not REM sleep in canine narcolepsy. Neuropsychopharmacology (2000) 0.87
Hyperactivity and hyperconnectivity of the default network in schizophrenia and in first-degree relatives of persons with schizophrenia. Proc Natl Acad Sci U S A (2009) 6.09
Control of sleep and wakefulness. Physiol Rev (2012) 3.06
Abnormal neural synchrony in schizophrenia. J Neurosci (2003) 3.05
Neural synchrony indexes disordered perception and cognition in schizophrenia. Proc Natl Acad Sci U S A (2004) 2.94
Uncinate fasciculus findings in schizophrenia: a magnetic resonance diffusion tensor imaging study. Am J Psychiatry (2002) 2.84
Adenosine and sleep-wake regulation. Prog Neurobiol (2004) 2.84
Cingulate fasciculus integrity disruption in schizophrenia: a magnetic resonance diffusion tensor imaging study. Biol Psychiatry (2003) 2.78
Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins/hypocretins. J Neurosci (2003) 2.43
Spatial normalization of diffusion tensor MRI using multiple channels. Neuroimage (2003) 2.39
Progressive and interrelated functional and structural evidence of post-onset brain reduction in schizophrenia. Arch Gen Psychiatry (2007) 2.13
White matter hemisphere asymmetries in healthy subjects and in schizophrenia: a diffusion tensor MRI study. Neuroimage (2004) 2.09
A hierarchical algorithm for MR brain image parcellation. IEEE Trans Med Imaging (2007) 2.05
Sensory-evoked gamma oscillations in chronic schizophrenia. Biol Psychiatry (2008) 1.98
Progressive decrease of left Heschl gyrus and planum temporale gray matter volume in first-episode schizophrenia: a longitudinal magnetic resonance imaging study. Arch Gen Psychiatry (2003) 1.94
Sleep and brain energy levels: ATP changes during sleep. J Neurosci (2010) 1.88
Using the logarithm of odds to define a vector space on probabilistic atlases. Med Image Anal (2007) 1.86
A prospective longitudinal volumetric MRI study of superior temporal gyrus gray matter and amygdala-hippocampal complex in chronic schizophrenia. Schizophr Res (2009) 1.82
Logarithm odds maps for shape representation. Med Image Comput Comput Assist Interv (2006) 1.79
Amygdala-hippocampal shape differences in schizophrenia: the application of 3D shape models to volumetric MR data. Psychiatry Res (2002) 1.78
Progressive decrease of left superior temporal gyrus gray matter volume in patients with first-episode schizophrenia. Am J Psychiatry (2003) 1.75
Gamma-band auditory steady-state responses are impaired in first episode psychosis. Biol Psychiatry (2008) 1.75
MRI study of caudate nucleus volume and its cognitive correlates in neuroleptic-naive patients with schizotypal personality disorder. Am J Psychiatry (2002) 1.72
Increased diffusivity in superior temporal gyrus in patients with schizophrenia: a Diffusion Tensor Imaging study. Schizophr Res (2009) 1.70
Hippocampal synaptic plasticity and spatial learning are impaired in a rat model of sleep fragmentation. Eur J Neurosci (2006) 1.70
Excessive extracellular volume reveals a neurodegenerative pattern in schizophrenia onset. J Neurosci (2012) 1.69
Shape of caudate nucleus and its cognitive correlates in neuroleptic-naive schizotypal personality disorder. Biol Psychiatry (2004) 1.66
Mismatch negativity in chronic schizophrenia and first-episode schizophrenia. Arch Gen Psychiatry (2002) 1.66
Middle and inferior temporal gyrus gray matter volume abnormalities in chronic schizophrenia: an MRI study. Am J Psychiatry (2004) 1.64
A pharmacological model for psychosis based on N-methyl-D-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities. Biol Psychiatry (2006) 1.57
A1 receptor and adenosinergic homeostatic regulation of sleep-wakefulness: effects of antisense to the A1 receptor in the cholinergic basal forebrain. J Neurosci (2003) 1.54
Corpus callosum abnormalities and their association with psychotic symptoms in patients with schizophrenia. Biol Psychiatry (2010) 1.45
Neuropsychological correlates of diffusion tensor imaging in schizophrenia. Neuropsychology (2004) 1.43
Voxel-based morphometric multisite collaborative study on schizophrenia. Schizophr Bull (2008) 1.43
Left auditory cortex gamma synchronization and auditory hallucination symptoms in schizophrenia. BMC Neurosci (2009) 1.43
Fronto-temporal disconnectivity in schizotypal personality disorder: a diffusion tensor imaging study. Biol Psychiatry (2005) 1.41
Orbitofrontal volume deficit in schizophrenia and thought disorder. Brain (2007) 1.40
Neocortical gray matter volume in first-episode schizophrenia and first-episode affective psychosis: a cross-sectional and longitudinal MRI study. Biol Psychiatry (2007) 1.40
Age-related deficits in fronto-temporal connections in schizophrenia: a diffusion tensor imaging study. Schizophr Res (2008) 1.38
Reduction of caudate nucleus volumes in neuroleptic-naïve female subjects with schizotypal personality disorder. Biol Psychiatry (2006) 1.36
Fusiform gyrus volume reduction and facial recognition in chronic schizophrenia. Arch Gen Psychiatry (2003) 1.33
Fusiform gyrus volume reduction in first-episode schizophrenia: a magnetic resonance imaging study. Arch Gen Psychiatry (2002) 1.29
A cross-sectional and longitudinal magnetic resonance imaging study of cingulate gyrus gray matter volume abnormalities in first-episode schizophrenia and first-episode affective psychosis. Arch Gen Psychiatry (2008) 1.27
Functional and structural deficits in brain regions subserving face perception in schizophrenia. Am J Psychiatry (2006) 1.27
Differences and similarities in insular and temporal pole MRI gray matter volume abnormalities in first-episode schizophrenia and affective psychosis. Arch Gen Psychiatry (2003) 1.22
Semantic bias, homograph comprehension, and event-related potentials in schizophrenia. Clin Neurophysiol (2002) 1.21
Fornix integrity and hippocampal volume in male schizophrenic patients. Biol Psychiatry (2006) 1.19
Extensive white matter abnormalities in patients with first-episode schizophrenia: a Diffusion Tensor Iimaging (DTI) study. Schizophr Res (2013) 1.19
Attentional networks and cingulum bundle in chronic schizophrenia. Schizophr Res (2006) 1.18
Functional diversity of ventral midbrain dopamine and GABAergic neurons. Mol Neurobiol (2004) 1.18
Gamma oscillation deficits and the onset and early progression of schizophrenia. Harv Rev Psychiatry (2010) 1.17
Neuropsychological disturbance in schizophrenia: a diffusion tensor imaging study. Neuropsychology (2008) 1.17
The application of DTI to investigate white matter abnormalities in schizophrenia. Ann N Y Acad Sci (2005) 1.16
On evaluating brain tissue classifiers without a ground truth. Neuroimage (2007) 1.16
Characterization of GABAergic neurons in rapid-eye-movement sleep controlling regions of the brainstem reticular formation in GAD67-green fluorescent protein knock-in mice. Eur J Neurosci (2008) 1.14
Sleep deprivation upregulates A1 adenosine receptors in the rat basal forebrain. Neuroreport (2007) 1.13
Prefrontal cortical thickness in first-episode psychosis: a magnetic resonance imaging study. Biol Psychiatry (2004) 1.13
Thalamo-frontal white matter alterations in chronic schizophrenia: a quantitative diffusion tractography study. Hum Brain Mapp (2009) 1.12
Experimental sleep fragmentation impairs attentional set-shifting in rats. Sleep (2007) 1.12
The brain in schizotypal personality disorder: a review of structural MRI and CT findings. Harv Rev Psychiatry (2001) 1.12
Reductions in the N1 and P2 auditory event-related potentials in first-hospitalized and chronic schizophrenia. Schizophr Bull (2009) 1.11
Comparison of single-shot echo-planar and line scan protocols for diffusion tensor imaging. Acad Radiol (2004) 1.11
Episodic memory and neuroimaging of hippocampus and fornix in chronic schizophrenia. Psychiatry Res (2007) 1.11
REM sleep changes in rats induced by siRNA-mediated orexin knockdown. Eur J Neurosci (2006) 1.11
Evidence for white matter abnormalities in schizophrenia. Curr Opin Psychiatry (2005) 1.10
Middle and inferior temporal gyrus gray matter volume abnormalities in first-episode schizophrenia: an MRI study. Am J Psychiatry (2006) 1.10
Altered orbitofrontal sulcogyral pattern in schizophrenia. Brain (2007) 1.10
An MRI study of spatial probability brain map differences between first-episode schizophrenia and normal controls. Neuroimage (2004) 1.09
Sleep deprivation in rats produces attentional impairments on a 5-choice serial reaction time task. Sleep (2006) 1.07
Experimental sleep fragmentation and sleep deprivation in rats increases exploration in an open field test of anxiety while increasing plasma corticosterone levels. Behav Brain Res (2008) 1.06
Longitudinal loss of gray matter volume in patients with first-episode schizophrenia: DARTEL automated analysis and ROI validation. Neuroimage (2011) 1.05
Long-range synchrony of γ oscillations and auditory hallucination symptoms in schizophrenia. Int J Psychophysiol (2010) 1.05
Decoupling of sleepiness from sleep time and intensity during chronic sleep restriction: evidence for a role of the adenosine system. Sleep (2012) 1.04
Predicting inter-hemispheric transfer time from the diffusion properties of the corpus callosum in healthy individuals and schizophrenia patients: a combined ERP and DTI study. Neuroimage (2010) 1.04
Shape differences in the corpus callosum in first-episode schizophrenia and first-episode psychotic affective disorder. Am J Psychiatry (2002) 1.04
Microdialysis elevation of adenosine in the basal forebrain produces vigilance impairments in the rat psychomotor vigilance task. Sleep (2008) 1.04
Personality differences in schizophrenia are related to performance on neuropsychological tasks. J Nerv Ment Dis (2005) 1.02
The NoGo P300 'anteriorization' effect and response inhibition. Clin Neurophysiol (2004) 1.01
Sleep deprivation triggers inducible nitric oxide-dependent nitric oxide production in wake-active basal forebrain neurons. J Neurosci (2010) 1.01
An MRI study of temporal lobe abnormalities and negative symptoms in chronic schizophrenia. Schizophr Res (2002) 1.00
White matter tract abnormalities between rostral middle frontal gyrus, inferior frontal gyrus and striatum in first-episode schizophrenia. Schizophr Res (2013) 1.00
Sleep deprivation increases A(1) adenosine receptor density in the rat brain. Brain Res (2008) 1.00
Sleep deprivation-induced protein changes in basal forebrain: implications for synaptic plasticity. J Neurosci Res (2005) 0.99
Hearing voices: a role of interhemispheric auditory connectivity? World J Biol Psychiatry (2011) 0.99
Method for combining information from white matter fiber tracking and gray matter parcellation. AJNR Am J Neuroradiol (2004) 0.99
Molecular profiles of pyramidal neurons in the superior temporal cortex in schizophrenia. J Neurogenet (2014) 0.99
Spatial learning and memory deficits following exposure to 24 h of sleep fragmentation or intermittent hypoxia in a rat model of obstructive sleep apnea. Brain Res (2009) 0.98
The time course of adenosine, nitric oxide (NO) and inducible NO synthase changes in the brain with sleep loss and their role in the non-rapid eye movement sleep homeostatic cascade. J Neurochem (2010) 0.98
Impact of ketamine on neuronal network dynamics: translational modeling of schizophrenia-relevant deficits. CNS Neurosci Ther (2013) 0.98
Neurophysiological mechanisms of sleep and wakefulness: a question of balance. Semin Neurol (2004) 0.98
Uncinate fasciculus abnormalities in recent onset schizophrenia and affective psychosis: a diffusion tensor imaging study. Schizophr Res (2009) 0.98
Functional neuroimaging of word priming in males with chronic schizophrenia. Neuroimage (2007) 0.98
The startle reflex in schizophrenia: habituation and personality correlates. Schizophr Res (2003) 0.97